Trial intelligence / Profile preview

COL-1620 for Luteal Phase Support in IVF/ET

NCT01863680Phase 3Completed

Sponsor
Merck KGaA
Start
Jul 2013
Primary completion
Oct 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Crinone in infertility, sponsored by Merck KGaA. Started Jul 2013; status: completed.

02

Drugs

Crinone
03

Conditions

infertility

Beyond the preview

Go deeper on NCT01863680.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01863680.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call